- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Vice President JD Vance on Wednesday (Nov. 12) credited the administration’s partnerships with private industry for advancing “most favored nation” drug pricing efforts and criticized congressional Democrats for refusing to engage on the issue -- even as a similar proposal from Senate health committee Chair Bill Cassidy (R-LA) failed to gain traction among Republicans and was left out of the summer’s reconciliation package.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us